Beverley Hunt

Leading Thrombosis Specialists Issue Clinical Guidance on the Diagnosis, Prevention and Treatment of Venous Thromboembolism in Hospitalized Patients with COVID-19

Retrieved on: 
Wednesday, May 27, 2020
Hematology, Medical specialties, Medicine, Body fluids, Venous thrombosis, Thrombosis, Beverley Hunt, Lifeblood, the Thrombosis Charity

The recommendations are published in a new paper, titled "Clinical Guidance on the Diagnosis, Prevention and Treatment of Venous Thromboembolism in Hospitalized Patients with COVID-19," published on May 27, 2020 in the Journal of Thrombosis and Haemostasis (JTH).

Key Points: 
  • The recommendations are published in a new paper, titled "Clinical Guidance on the Diagnosis, Prevention and Treatment of Venous Thromboembolism in Hospitalized Patients with COVID-19," published on May 27, 2020 in the Journal of Thrombosis and Haemostasis (JTH).
  • The peer-reviewed paper outlines new practical guidance on the prevention and treatment of VTE in hospitalized patients with COVID-19.
  • The recommendations were developed by a multidisciplinary panel of thrombosis experts as a response to widespread clinical reports of unusual, difficult-to-control clotting in COVID-19 patients.
  • For more information on the paper, "Clinical Guidance on the Diagnosis, Prevention and Treatment of Venous Thromboembolism in Hospitalized Patients with COVID-19," visit https://onlinelibrary.wiley.com/doi/abs/10.111/jth.14929.

World Thrombosis Day Empowers People Around the World to Recognize and Help Prevent Life-Threatening Blood Clots

Retrieved on: 
Wednesday, October 9, 2019
Medical specialties, Hematology, Blood, Medicine, Beverley Hunt, Thrombosis, International Society on Thrombosis and Haemostasis, Deep vein thrombosis, Venous thrombosis, Thrombus, Deep vein, Thrombosis prevention

VTE occurs when one or more blood clots form in a deep vein, most often in the leg (deep vein thrombosis).

Key Points: 
  • VTE occurs when one or more blood clots form in a deep vein, most often in the leg (deep vein thrombosis).
  • "Hospital-acquired blood clots are a global problem," says Prof. Beverley Hunt, OBE, chair of the World Thrombosis Day Steering Committee.
  • Because of this, the World Thrombosis Day campaign places a global spotlight on hospital-acquired blood clots to raise awareness of this common and under-recognized preventable health issue."
  • World Thrombosis Day is on October 13 each year and is led by the International Society on Thrombosis and Haemostasis (ISTH) .

World Thrombosis Day Empowers People Around the World to Recognize and Help Prevent Life-Threatening Blood Clots

Retrieved on: 
Wednesday, October 9, 2019
Medical specialties, Hematology, Blood, Medicine, Beverley Hunt, Thrombosis, International Society on Thrombosis and Haemostasis, Deep vein thrombosis, Venous thrombosis, Thrombus, Deep vein, Thrombosis prevention

VTE occurs when one or more blood clots form in a deep vein, most often in the leg (deep vein thrombosis).

Key Points: 
  • VTE occurs when one or more blood clots form in a deep vein, most often in the leg (deep vein thrombosis).
  • "Hospital-acquired blood clots are a global problem," says Prof. Beverley Hunt, OBE, chair of the World Thrombosis Day Steering Committee.
  • Because of this, the World Thrombosis Day campaign places a global spotlight on hospital-acquired blood clots to raise awareness of this common and under-recognized preventable health issue."
  • World Thrombosis Day is on October 13 each year and is led by the International Society on Thrombosis and Haemostasis (ISTH) .

Blood Clot Survivor from Poland Recognized as World Thrombosis Day 2019 Ambassador of the Year

Retrieved on: 
Tuesday, October 8, 2019
Blood, International Society on Thrombosis and Haemostasis, Beverley Hunt, Academic journals, Thrombosis, Medical specialties, Body fluids

CHAPEL HILL, North Carolina, Oct. 8, 2019 /PRNewswire/ -- The International Society on Thrombosis and Haemostasis (ISTH) today announced that Kamila Jaszczor has been named the World Thrombosis Day 2019 Thrombosis Ambassador of the Year.

Key Points: 
  • CHAPEL HILL, North Carolina, Oct. 8, 2019 /PRNewswire/ -- The International Society on Thrombosis and Haemostasis (ISTH) today announced that Kamila Jaszczor has been named the World Thrombosis Day 2019 Thrombosis Ambassador of the Year.
  • This important recognition highlights Jaszczor's international commitment to achieving the World Thrombosis Day campaign's mission of shining a global spotlight on the condition of thrombosis.
  • "We are incredibly honored to recognize Kamila Jaszczor for this prestigious award," said Prof. Beverley Hunt, OBE, Chair of the World Thrombosis Day Steering Committee.
  • She embodies everything that it means to be the World Thrombosis Day Ambassador of the Year, and we are so proud to recognize her efforts."

Professor Beverley Hunt Recognized as Officer of the Most Excellence Order of the British Empire for Service to Medicine

Retrieved on: 
Saturday, June 8, 2019
Hematology, Coagulation system, Thrombosis, Hemostasis, Beverley Hunt

Hunt is an internationally recognized expert in thrombosis and acquired bleeding disorders.

Key Points: 
  • Hunt is an internationally recognized expert in thrombosis and acquired bleeding disorders.
  • "I can think of few more inspiring women in the international field of thrombosis and haemostasis than Beverley.
  • "Beverley is a unique talent, a thoughtful and intelligent clinician scientist, and a very caring doctor who always keeps the needs of her patients in focus.
  • I am immensely proud to call her my friend and to be one of her many global colleagues."

ASH Releases New Clinical Practice Guidelines for Venous Thromboembolism

Retrieved on: 
Tuesday, November 27, 2018
Health, Health informatics, Healthcare quality, Hematology, Clinical research, Medical guideline, Medical terminology, Venous thrombosis, Guideline, Evidence-based medicine, Beverley Hunt

Today, ASH announced the results of their collective efforts the 2018 ASH Clinical Practice Guidelines on Venous Thromboembolism in a press event timed to the publication of the first six chapters in the Society's peer-reviewed journal Blood Advances.

Key Points: 
  • Today, ASH announced the results of their collective efforts the 2018 ASH Clinical Practice Guidelines on Venous Thromboembolism in a press event timed to the publication of the first six chapters in the Society's peer-reviewed journal Blood Advances.
  • The 10 evidence-based clinical guidelines chapters cover VTE through a number of lenses, in areas in which there is currently uncertainty and variation in clinical practice:
    The 2018 ASH guidelines were developed using state-of-the-art methodology to ensure they meet the highest standards for trustworthiness and transparency.
  • The 2018 ASH guidelines are the first of a larger guideline development initiative for ASH, which includes a commitment to the timely update of existing guidelines and the development of new ones on a range of hematologic conditions.
  • ASH publishesBlood( www.bloodjournal.org ), the most cited peer-reviewed publication in the field, which is available weekly in print and online.

Breakthrough Strategy Leads International Society on Thrombosis and Haemostasis Global Venous Thrombosis Research Project

Retrieved on: 
Monday, November 26, 2018
Hematology, Blood, International Society on Thrombosis and Haemostasis, Health, Medicine, Structure, Beverley Hunt

ELLICOTT CITY, Md., Nov.26, 2018 /PRNewswire/ --Breakthrough Strategy (BTS), working on behalf of the International Society on Thrombosis and Haemostasis (ISTH), will lead an international project to develop venous thromboembolism (VTE) clinical research standards beginning in December 2018.

Key Points: 
  • ELLICOTT CITY, Md., Nov.26, 2018 /PRNewswire/ --Breakthrough Strategy (BTS), working on behalf of the International Society on Thrombosis and Haemostasis (ISTH), will lead an international project to develop venous thromboembolism (VTE) clinical research standards beginning in December 2018.
  • BTS and ISTH plan to submit the final data set to one or more clinical research standards organizations, to be considered for endorsement as an international research standard.
  • The International Society on Thrombosis and Haemostasis is a global not-for-profit membership organization advancing the understanding, prevention, diagnosis and treatment of thrombotic and bleeding disorders.
  • Breakthrough Strategy, a Maryland-based consulting firm, provides program design, business strategy, and market research services to nonprofit medical societies, membership associations, and healthcare enterprises.